Clinical Trials Logo

Body Weight clinical trials

View clinical trials related to Body Weight.

Filter by:

NCT ID: NCT03858816 Withdrawn - Clinical trials for Very Low Birth Weight Infants

Efficacy of Multiple Strain Probiotics Reduces the Neurobehavioral Disorder in Premature Very Low Birth Weight Infants

Start date: June 14, 2018
Phase: N/A
Study type: Interventional

The management protocols, clinical practices, equipment, infrastructure, and key personnel in NICU are unchanged during the study period. The data collected by each center are transmitted to the office of the principal investigator (Dr Lin) at China Medical University Hospital. Primary outcome is death or attention deficit and hyperactivity disorder (ADHD) and ASD.

NCT ID: NCT03857204 Not yet recruiting - Fetal Weight Clinical Trials

Fetus Weight Estimation by Ultrasound Data Collection

Start date: March 1, 2020
Phase: N/A
Study type: Interventional

This research aims to allow deployment & optimization of SAMPL plain wave algorithm so as to make required advancement towards a light-weight portable US platform or wireless probe - thus elevating clinician's care level and patient treatment by allowing more scan availability and flexibility.

NCT ID: NCT03853603 Completed - Weight Loss Clinical Trials

Clinical Study to Investigate the Effects of a Food Supplement Santa Herba Extract on Weight Loss in Overweight Women

Start date: February 15, 2019
Phase: N/A
Study type: Interventional

Aim of the study is to investigate the effect of a 12-week supplementation of Santa Herba Extract on body weight in overweight and obese subjects. Additionally appetite related marker as well as marker of white adipose tissue browning will be evaluated.

NCT ID: NCT03850990 Completed - Obesity Clinical Trials

Effect of Gut-Cued Eating on BMI and Efficacy of Open-Label Placebo to Augment Weight Loss

GCE
Start date: September 25, 2019
Phase: N/A
Study type: Interventional

The study will assess the effect of attending to stomach-cues of hunger and fullness on body weight and any additional benefit provided by open-label placebo.

NCT ID: NCT03844646 Terminated - Weight Loss Clinical Trials

Continuous Glucose Monitoring to Aid Weight Loss in Prediabetes

Start date: August 1, 2019
Phase: N/A
Study type: Interventional

The primary objective of this study is to determine whether intermittent use of continuous glucose monitor will facilitate weight loss in individuals who are overweight/obese with prediabetes.

NCT ID: NCT03843424 Active, not recruiting - Overweight Clinical Trials

Treatment Efforts Addressing Child Weight Management by Unifying Patients, Parents & Providers

TEAM UP
Start date: September 12, 2019
Phase: N/A
Study type: Interventional

The US Preventive Services Task Force (USPSTF) recommends that providers screen children aged 6 years and older for obesity and offer or refer them to a comprehensive behavioral intervention (≥26 hours over a period of up to 12 months) to promote improvement in weight status. Family-based behavioral treatment (FBT) is an effective treatment that targets both child and parents and meets the USPSTF recommendations. By contrast, the American Medical Association (AMA) recommends a staged approach to childhood obesity screening and counseling, which begins with prevention counseling by the primary care provider (PCP) and includes assessment of weight status, patient/family motivation and readiness to change, promotion of healthy eating and activity habits, and use of health behavior change strategies. Our study compares a staged approach enhanced standard of care (eSOC) vs. eSOC + FBT, to provide families and PCPs with information on the best intervention approach for the behavioral treatment of childhood obesity. Our project seeks to fill the gap in the evidence on family-based weight management in primary care settings among diverse and underserved populations with a special focus on Black children, families insured by Medicaid, and sex differences.

NCT ID: NCT03840733 Enrolling by invitation - Obesity Clinical Trials

Linking Temporal Patterns of Modifiable Behaviors to Weight Loss Outcomes

Start date: January 7, 2019
Phase:
Study type: Observational [Patient Registry]

This study is designed as an observational trial. The objective of this study is to follow-up with participants 3 years after completion of an 18-month comprehensive behavioral weight loss intervention. Outcomes of interest include change in body weight, body composition, physical activity, energy intake, and sleep. In addition, investigators will explore the associations between current physical activity, sleep, and energy intake patterns and body weight regulation.

NCT ID: NCT03834194 Completed - Clinical trials for Gestational Weight Gain

Gestational Weight and Incentive Research Study

Bloom
Start date: February 26, 2019
Phase: N/A
Study type: Interventional

Bloom is a research study that examines whether incentives for daily self-weighing, weekly physical activity, monthly weight management or overall (from enrollment up to 36 weeks pregnancy) weight management could help pregnant mothers manage a health weight gain during pregnancy.

NCT ID: NCT03830437 Completed - Clinical trials for Cortisol Overproduction

Salivary Cortisol as Stress Marker in Newborns Subjected to Double Weighing With Physiological Body Weight

Start date: September 21, 2018
Phase:
Study type: Observational

According to scientific revisions, salivary cortisol is a valid method for measuring adrenocortical activity in newborns because it is non-invasive in fact the measurement of salivary cortisol has been used as a stress marker in newborns since 1992. The mechanism by which cortisol induces stress, concerns the hypothalamic-pituitary-adrenal axis. The hypothalamus produces the corticotropin-releasing hormone, which stimulates the production of adrenocorticotropin by hypophysis. Adrenocorticotropin induces the secretion of glucocorticoids such as cortisol by stimulating the cortex of the adrenal gland. An appropriate release of cortisol due to stress factor is vital for surviving and the loss of this mechanism increase the risk of morbidity and mortality for newborns. However, prolonged exposure to a high level of cortisol may increase the risk of cognitive and behavioural disorders, hypertension, hyperlipidaemia, insulin resistance, immune deficiency and hippocampal impairment. The separation from the mother, the exposure to painful procedures but also routine interventions such as physical examination, diaper changes and bathing increase the salivary cortisol level of the newborn compared to the basal state. The measurement of salivary cortisol in the newborn therefore has the aim of understanding and preventing those stressful conditions that may have long-term side effects. For this reason, the lose weight in the first days and double weighing should be a stress practice for the newborn.

NCT ID: NCT03819478 Completed - Obesity Clinical Trials

Utilizing Protein During Weight Loss to Impact Physical Function and Bone

UPLIFT-Bone
Start date: May 3, 2017
Phase: N/A
Study type: Interventional

This study is an ancillary study to the Utilizing Protein During Weight Loss to Impact Physical Function (UPLIFT) trial (NCT03074643) to evaluate the effects of diet composition (i.e., amount of protein and carbohydrate) during a 6-month weight loss intervention and 12-months of follow-up on bone phenotypes in obese older adults. Participants will receive either a protein or carbohydrate supplement along with a behavioral weight loss intervention.